NCT05818358

Brief Summary

This is a single site, single-blinded, controlled randomized crossover clinical trial designed to compare the effects of black beans or whole grains or white rice at breakfast on postprandial vascular responses in males and females with arterial stiffness (n=10). Eligible participants will be asked to attend 3 in-person visits for comparative testing of black beans versus whole grains versus white rice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

March 16, 2023

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline Augmentation index at 2 hours

    Pulse wave analysis using a SphygmoCor XCEL device will be used to measure the augmentation index (AIx), an indicator of arterial stiffness, prior to consumption of the test products, and at 2 hours post-consumption.

    Time points 0 (prior to consumption) and 2 hours post consumption.

  • Change from baseline Reflection magnitude at 2 hours

    Pulse wave analysis using a SphygmoCor XCEL device will be used to measure the reflection magnitude, an indicator of arterial stiffness, prior to consumption of the test products, and at 2 hours post-consumption.

    Time points 0 (prior to consumption) and 2 hours post consumption.

Secondary Outcomes (1)

  • Change from baseline blood pressure at 2 hours

    Time points 0 (prior to consumption) and 2 hours post consumption.

Study Arms (3)

Black Beans (cooked)

ACTIVE COMPARATOR

At one of the three visits, participants will consume a ¾ cup of cooked black beans. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.

Dietary Supplement: black beans

Whole Wheat Grain (cooked)

ACTIVE COMPARATOR

At one of the three visits, participants will consume a ¾ cup of cooked whole wheat grain. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.

Dietary Supplement: wheat berries

White Rice (cooked)

PLACEBO COMPARATOR

At one of the three visits, participants will consume a ¾ cup of cooked white rice. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.

Dietary Supplement: white rice

Interventions

black beansDIETARY_SUPPLEMENT

¾ cup of cooked black beans

Black Beans (cooked)
wheat berriesDIETARY_SUPPLEMENT

¾ cup of cooked whole wheat grain

Whole Wheat Grain (cooked)
white riceDIETARY_SUPPLEMENT

¾ cup of cooked white rice

White Rice (cooked)

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male, or non-pregnant, non-lactating female, 45 to 65 years of age;
  • Brachial-ankle pulse wave velocity \>1400 cm/s on at least one side;
  • Plasma creatinine ≤265 µmol/L;
  • Aspartate aminotransferase \<160 U/L, andalanine aminotransferase \<150 U/L;
  • Glycated hemoglobin ≤6.5%;
  • LDL-cholesterol \<5 mmol/L;
  • Stable regime if taking vitamin and mineral/dietary/herbal supplements for the past 1 month and while participating in the study;
  • Has not donated blood or blood products (e.g. platelets) during the past 2 months and willing to continue doing so while participating in the study;
  • Not participating in another dietary intervention trial for the past month and willing to not start another dietary intervention trial for the duration of this study;
  • Willing to comply with the protocol requirements and procedures;
  • Willing to provide informed consent.

You may not qualify if:

  • Has experienced a cardiovascular event (e.g. heart attack, stroke) or had a surgical procedure for cardiovascular disease (e.g. bypass, stent), presence of clinically diagnosed cardiac arrhythmia or valve stenosis, chronic renal disease, liver disease (with exception of fatty liver), lung disease, rheumatoid arthritis, immune disorder or disease (e.g. multiple sclerosis, leukemia), cancer in the previous 5 years, neurological disorders, or gastrointestinal disorders;
  • Taking vasoactive medications (e.g., ACE inhibitors, ARBs, AGE-breakers, thiazolidinediones, beta-blockers, statins, insulin, etc.);
  • Blood pressure \>160 mmHg systolic and/or \>100 mmHg diastolic;
  • History of gastrointestinal reactions or allergies to beans, bean flour, wheat, wheat flour, gluten, or rice;
  • Body weight exceeds the capacity of the DEXA (350 lbs);
  • Current (within the past 30 days) bacterial, viral or fungal infection;
  • Bleeding disorder;
  • Amputations of upper or lower extremities on both sides;
  • Any acute medical condition or surgical intervention within the past 3 months;
  • Drug and/or alcohol abuse;
  • Psychological disorder(s);
  • Unable to fast overnight;
  • Unable to take prescribed medication without food;
  • Unable to obtain vascular function measurements and/or blood sample at the screening or first study visits;
  • Not fully vaccinated for COVID-19.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asper Clinical Research Institute

Winnipeg, Manitoba, R3E 0T5, Canada

Location

Related Publications (1)

  • Zahradka P, Perera D, Charney J, Taylor CG. Distinct Effects of Wheat and Black Bean Consumption on Postprandial Vascular Responses in People with Arterial Stiffness: A Pilot Randomized Cross-Over Study. Nutrients. 2025 Mar 27;17(7):1159. doi: 10.3390/nu17071159.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

March 16, 2023

First Posted

April 18, 2023

Study Start

April 1, 2023

Primary Completion

March 22, 2024

Study Completion

April 30, 2024

Last Updated

February 28, 2025

Record last verified: 2025-02

Locations